A novel stability-indicating UHPLC method for the determination of related substances and assay in a synthetic opioid peptide Difelikefalin acetate and LC–MS identification of the major degradation products
Key Points
Difelikefalin acetate shows consistent stability when assessed with a novel UHPLC method—confirming its suitability for detailed analysis.
The assessment identifies degradation products effectively, demonstrating a significant metric of stability and reliability in analysis.
Employing UHPLC coupled with LC-MS techniques, the method reveals major degradation products efficiently under controlled conditions.
Results support the ongoing use of Difelikefalin in clinical settings, calling for confidence in its stability and effectiveness against degradation.
Une nouvelle méthode UHPLC indiquant la stabilité pour la détermination des substances apparentées et l'essai dans un peptide opioïde synthétique Difelikefalin acétate et identification LC–MS des principaux produits de dégradation. | Synapse